Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects

This publication has 293 references indexed in Scilit:

• Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
  American Heart Journal, 2003
• Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function
  Journal of the American College of Cardiology, 2001
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy
  The American Journal of Cardiology, 2000
• Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion
  The American Journal of Cardiology, 1996
• Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention
  The American Journal of Cardiology, 1995
• Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris
  The Lancet, 1992
• Isolation and covalent structure of the aspirin-modified, active-site region of prostaglandin synthetase
  Biochemistry, 1983
• Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole
  The American Journal of Cardiology, 1983
• Prevention of arterial thromboembolism with acetylsalicylic acid
  American Heart Journal, 1977